three-dimensional compound structure library (Chembridge)
90
Structured Review
Chembridge
three-dimensional compound structure library
Three Dimensional Compound Structure Library, supplied by Chembridge, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/three-dimensional+structures/3d+structure+library/pm40333783-2-31-34
Average 90 stars, based on 1 article reviews
Three Dimensional Compound Structure Library, supplied by Chembridge, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/three-dimensional+structures/3d+structure+library/pm40333783-2-31-34
Average 90 stars, based on 1 article reviews
three-dimensional compound structure library - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Discovery of Novel Antimicrobial-Active Compounds and Their Analogues by In Silico Small Chemical Screening Targeting Staphylococcus aureus MurB Article Snippet: We used a 3D structure library of Article Title: Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of Cancer: A Review. Article Snippet: Tyrosine kinases are known to play a role in tumour growth and proliferation, and they have become common drug targets.. Tyrosine kinase inhibitors (TKIs) prohibit associated kinases from phosphorylating tyrosine residues in their substrates, preventing downstream signaling pathways from being activated.. Multiple robust and well-tolerated TKIs targeting single or multiple targets, including EGFR, ALK, ROS1, HER2, NTRK, VEGFR, RET, MET, MEK, FGFR, PDGFR, and KIT, have been developed over the last two decades, contributing to our understanding of precision cancer medicine based on a patient's genetic alteration profile. Article Title: Discovery of Antibacterial Compounds with Potential Multi-Pharmacology against Staphylococcus Mur ligase Family Members by In Silico Structure-Based Drug Screening Article Snippet: The compound structure data library used in this study is the In Silico:Article Title: Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro. Article Snippet: .. To identify compounds that bind to the β-chain of HGF and inhibit signaling through HGF and its receptor Met interaction, we performed a hierarchical in silico drug screen using a three-dimensional Article Title: Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro Article Snippet: .. The Article Title: Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro. Article Snippet: .. The Binding Assay:Article Title: Discovery of Antibacterial Compounds with Potential Multi-Pharmacology against Staphylococcus Mur ligase Family Members by In Silico Structure-Based Drug Screening Article Snippet: .. Docking simulations were performed using Auto Dock Vina 1.1.2 (ADV) [ ] for the substrate binding sites of MurE with the Generated:Article Title: Identification of Novel Influenza Polymerase PB2 Inhibitors Using a Cascade Docking Virtual Screening Approach Article Snippet: .. LibDock was used to perform high-throughput screening of the generated |
![Coumarin <t>derivatives</t> can selectively bind to RNA G 1 × 0 bulges: ( A ) RNA structures of the 1 × 0 RNA bulges used for in vitro binding profiling using the FP assay. N = G , A , U , or C (RNA1-4). ( B ) Heatmap profile of the ΔmP = (FP RNA-ligand – FP ligand ) × 1000 for RNA binders in the presence of [RNA] = 5 or 1 μM (red = high polarization, blue = low polarization). ( C ) ΔmP of RNA-ligand complex for RNA ligands at 5 μM. Each data point represents a measurement of a ligand in the 69-compound collection. **** indicates P < .0001. ( D ) Dose-response curves for compounds (SMSM6, <t>C30)</t> selectively binding to the bulged G RNA (RNA1) compared to an 11-nucleotide GA-rich sequence that would form a double loop-like RNA structure measured by the FP assay.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8297/pmc12188297/pmc12188297__gkaf559fig2.jpg)
